Here at the Janssen Health Policy Centre
our mission is to raise awareness on issues impacting healthcare policy, build
consensus through dialogue, and shape recommendations for future policies

Reports archive






Against a backdrop of growing obesity levels across the EU, the Czech Republic holds the unfortunate distinction of having one of the region’s worst problems with excess weight. Studies suggest that over recent years the incidence of obesity has risen continuously.

more info


The Case of Blood Cancer: Innovation and the Economics of Healthcare

While innovation is central for the quality of healthcare and improving health outcomes, it is also a source of increasing costs for governments. Confronted by fiscal pressures, governments have made efforts to restrict access to innovative treatments. While such policies are understandable, they are not necessarily supportive of the ambition to control the cost burden of a disease. This paper reviews economic analyses of the cost burden of cancer, and blood cancers in particular, and the effects that innovative treatments have on other sources of costs in the healthcare system or the economy as a whole. Janssen recently sponsored the European Centre for International Political Economy (ECIPE) summit.

more info


Tackling Tuberculosis In South Africa

As a relatively wealthy African country and one of the BRICS nations (Brazil, Russia, India, China and South Africa), South Africa has been able to make more substantial investments in combating tuberculosis (TB) and multi-drug-resistant tuberculosis (MDR TB) than many others in the region. This, combined with strong political will, has put South Africa ahead of many of its peers in the fight against the disease.

more info


Tackling Tuberculosis in Kenya

With the help of international funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the United States Agency for International Development (USAID) and others, Kenya is planning to scale up its response to tuberculosis (TB) and multidrug-resistant tuberculosis (MDR TB) by 2017.1 But although the political will to fight the disease is there, experts and policymakers recognise that MDR TB cannot be tackled in isolation.

more info


Tackling Tuberculosis in Nigeria

For Nigeria, the barriers to tackling multidrug-resistant tuberculosis (MDR TB) include external factors such as the Boko Haram insurgency (which is also hampering the battle against polio). However, persistent weaknesses in the country’s health system that are lowering its diagnosis and treatment capacity are also contributing to Nigeria’s struggle to control tuberculosis (TB) and MDR TB.

more info

Report archive